"Coronavirus: Oxford vaccine triggers immune response"

[gracielle]

Cómo será la vacuna argentina contra el coronavirus | El Conicet trabaja en base a un método innovador que consiste en inocular una proteína para que el cuerpo produzca los anticuerpos

En declaraciones al programa #Caimialaseis que se emite por AM750, el ministro de Ciencia Roberto Salvarezza explicó los detalles del diseño del antídoto de producción nacional que el organismo científico está desarrollando junto a la Universidad del L...

www.pagina12.com.ar

28 January 2021
Excerpt from article....The Minister of Science, Roberto Salvarezza, added that the Oxford vaccine that is being manufactured in the country does not have any delay and that the first 6 million doses that were sent to Mexico for packaging have already come out and that another 6 million doses will come out in the coming days. "We hope this is in March because production is doing very well."....

 

[gracielle]

Coronavirus: Germany set to limit AstraZeneca jab to under-65s

German vaccine officials say there is not enough data about the jab, which is widely used in the UK.

www.bbc.com

Covid: EU-AstraZeneca disputed vaccine contract made public

The European Commission argues the drug-maker is failing to fulfil its promises on the Covid jab.

www.bbc.com

 

[gracielle]

Coronavirus: EU and AstraZeneca seek to resolve vaccine supply crisis

Both sides pledge to work together after a reported 50 million-dose shortfall for the 27-member EU.

www.bbc.com

Covid: UK experts back AstraZeneca jab amid Germany ruling

Public Health England says the AstraZeneca jab offers "high levels of protection" against Covid-19.

www.bbc.com

 

[MilHojas]

Press corner

Highlights, press releases and speeches

ec.europa.eu

Oxford/AstraZeneca vaccine has been approved by the European Medical Agency. They say that there is not enough data to judge its efficacy for people older than 55, but they think it should work anyway .

There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group. However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines; as there is reliable information on safety in this population, EMA's scientific experts considered that the vaccine can be used in older adults.

 

[gracielle]

Mexico to import AstraZeneca vaccine from India, president says | The Press Reporter

Mexico plans to import about 870,000 doses of AstraZeneca's COVID-19 vaccine from India in February, in addition to producing it regionally, President Andres Manuel Lopez Obrador mentioned on Fri

www.thepressreporter.in

 

[gracielle]

Coronavirus: qué vacunas negocia el Gobierno para febrero tras la demora de la Sputnik V

Coronavirus: qué vacunas negocia el Gobierno para febrero tras la demora de la Sputnik V

www.lanacion.com.ar

31 January 2021....By: Maia Jastreblansky
Coronavirus: what vaccines the Government negotiates for February after the delay of Sputnik V.

....The Oxford-Astrazeneca vaccine -whose active ingredient was manufactured in Argentina by the Insud Laboratory and has already been sent to Mexico for dosage, packaging and certification- scheduled its deliveries for March. The Government has the following schedule: 1.1 million in March, 4.6 million in April, 4.6 million in May, 3.4 million in June and 8.5 million in July. Last week, Hugo Sigman, the head of the Insud Laboratory, was at the Casa Rosada. After his visit, the officials were excited at the thought that they may have a first lot in the coming weeks....

 

[gracielle]

Hoy parten de Argentina hacia México otros 6 millones de activos para fabricar la vacuna de Oxford-AstraZeneca

Con este segundo embarque, el laboratorio del empresario y médico argentino Hugo Sigman ya lleva manufacturado material para 12 millones de vacunas

www.infobae.com

01 February 2021
Today another 6 million of the active material are leaving Argentina for Mexico to manufacture the Oxford-AstraZeneca vaccine....

....The second shipment of the active ingredient to manufacture 6 million Oxford-AstraZeneca vaccines will depart tonight from Ezeiza to Mexico. The Aeroméxico plane - prepared to carry up to 25 tons - is expected to take off at 10 p.m. The first had arrived in Mexico on January 20. The initiative takes place after the approval of the UK regulators - as INFOBAE had advanced - and the approval of the National Administration of Medicines, Food and Medical Technology (ANMAT) under the emergency use of this formula for its application in Argentina....

....In this sense, it could be said that little by little progress is being made towards the final stage of supplying 22.4 million doses of vaccines for Argentina and 150 million doses for the region.

“Today the vaccine against COVID-19 is a reality for Argentina and for the region that it integrates. Since the second quarter of 2020, we have worked tirelessly to understand what the best supply alternative was and to be able to bring the vaccine immediately to our country. Today we are moving towards the final steps of the manufacturing and supply process, and allowing our country and Latin America to have an effective, safe, easy to store (2-8 degrees) and tremendously accessible non-profit vaccine for the duration of the pandemic. The production plan is underway and the vaccine will be available during the first half of the year ”, Agustín Lamas, president of AstraZeneca for the Southern Cone, assured INFOBAE exclusively.

....Data published in early December in The Lancet medical journal indicated that the vaccine is 62% effective when two full doses of the vaccine are given, but 90% effective when half of the first dose is given. followed by a full one in the second.

It was the executive director of the pharmaceutical AstraZeneca, Pascal Soriot, who, at the end of December 2020, assured that the laboratory had found the "winning formula" to make its vaccine against COVID-19 have an effectiveness at the level of those of Pfizer / BioNTech, 95%, and Moderna, 94%. "We believe that we have found the winning formula to achieve an effectiveness that, after two doses, is as high as all the others," Soriot explained to the Sunday Sunday Times about the preparation that his company develops together with the University of Oxford.

 

[gracielle]

This article was originally posted on 1 Feb 2021 by lunar on the other thread...COVID-19 vaccine development pipeline gears up.

AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19

Following criticism over initial trial, pharma giant's CEO believes general efficacy will be equal to Pfizer-BioNTech, Moderna; says data will be published 'at some point'

www.timesofisrael.com

 

[antipodean]

Oxford vaccine could substantially cut spread

New data also shows the vaccine was 76% effective during the three months after the first dose.

www.bbc.com

 

[gracielle]

https://www.usnews.com/news/health-news/articles/2021-02-02/france-says-no-astrazeneca-virus-vaccine-for-people-over-65

Vaccines may protect against severe disease even as variants evolve, Oxford's Pollard says

COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.

www.reuters.com